Prothena Corporation PLC (NASDAQ:PRTA)

26.47
Delayed Data
As of Mar 02
 -0.11 / -0.41%
Today’s Change
16.71
Today|||52-Week Range
49.24
+27.50%
Year-to-Date

Today’s Trading

Previous close26.58
Today’s open26.66
Day’s range-- - --
Volume257,020
Average volume (3 months)258,693
Market cap$727.9M
Dividend yield--
Data as of 03/02/2015

Growth & Valuation

Earnings growth (last year)+22.54%
Earnings growth (this year)+77.30%
Earnings growth (next 5 years)-12.59%
Revenue growth (last year)-74.57%
P/E ratioNM
Price/Sales730.30
Price/Book3.35

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+1.08+4.35%
INFIInfinity Pharmaceuti...+0.76+5.00%
OMEDOncoMed Pharmaceutic...-0.37-1.48%
TBPHTheravance Biopharma...-1.00-4.60%
Data as of 03/02/2015

Financials

Next reporting dateMarch 6, 2015
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$676.0K
Annual profit (last year)-$41.0M
Net profit margin-6,064.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Dale B. Schenk
Chief Financial Officer &
Head-Investor Relations
Tran B. Nguyen
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account